Funds holding MUSTANG BIO INC
ISIN US62818Q3020 · United States · LEI 5493004W0VC1DPECQ779
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 55.4K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 30,943 | 31.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 25,704 | 18.7K $ | as of Mar 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 4,184 | 4.2K $ | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 1,077 | 1.1K $ | as of Feb 28, 2026 ↗ | |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 160 | 116.5 $ | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 62,068 | +24.3 % |
| 2026Q1 | 5 | 0 | 49,935 | +2.4 % |
| 2025Q4 | 5 | -1 | 48,761 | +180.9 % |
| 2025Q3 | 6 | 0 | 17,361 | +131.2 % |
| 2025Q2 | 6 | +5 | 7,509 | +375,350.0 % |
| 2025Q1 | 1 | 2 |
Institutional managers
20 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Kestra Advisory Services, LLC | 176,042 | 128.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 92,790 | 67.6K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 84,745 | 61.7K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 53,200 | 38.7K $ | as of Mar 31, 2026 |
| CFO4Life Group, LLC | 20,461 | 14.9K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 16,754 | 12.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 3,659 | 2.7K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,895 | 1.4K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 509 | 371 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 118 | 86 $ | as of Mar 31, 2026 |
| Cullen/Frost Bankers, Inc. | 13 | 9 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 6 | 4 $ | as of Mar 31, 2026 |
| MAI Capital Management | 3 | 3 $ | as of Mar 31, 2026 |
| NBC SECURITIES, INC. | 3 | 2 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 2 | 1 $ | as of Mar 31, 2026 |
| CWM, LLC | 2 | 1 $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2 | 1 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 2 | 1 $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 1 | 1 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 1 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding MUSTANG BIO INC". https://titelia.com/en/stocks/mustang-bio-inc-US62818Q3020